Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to families and caregivers.

Experts say early intervention is key to treating and coping with dementia or Alzheimer's. Here's what to keep an eye out for ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

There isn't a cure for the condition, but doctors may recommend medications to slow down the progression of the disease or ...

The first drug proven to slow down Alzheimer's won't be available to dementia patients in Scotland - unless they pay £60,000 ...

Diabetes is a common, lifelong condition that occurs when the pancreas doesn't produce enough insulin, or when the body is unable to effectively use the insulin it produces ...

The hypothesis puts forward the idea that stress granules disrupt the cell transport system, which then modifies gene ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Alzheimer’s Research UK funds research into treatment, diagnosis and prevention. Of particular importance is research which has translational potential to benefit people with or at risk of dementia.

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

Many researchers believe that Alzheimer’s happens because of harmful proteins building up in the brain, disrupting how brain ...